AMD is a major cause of vision impairment in older adults, with increasing global prevalence. It is primarily influenced by genetic and environmental factors like smoking, and its progression is characterized by either geographic atrophy or neovascularization. Treatment with anti-VEGF injections and nutritional supplements has been shown to slow progression and improve visual outcomes in patients with AMD. This evidence concerns the gene VEGFA and atrophic macular degeneration.